Related Experiment Video
Updated: May 31, 2026

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats
María E Frigolet1, Nimbe Torres, Armando R Tovar
1Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Seccion XVI, Mexico DF 14000, Mexico.
Abstract:
Several metabolic disturbances during obesity are associated with adipose tissue-altered functions. Adipocytes contain the renin-angiotensin system (RAS), which regulates signalling pathways that control angiogenesis via Akt in an autocrine fashion. Soya protein (Soy) consumption modifies the gene expression pattern in adipose tissue, resulting in an improved adipocyte function. Therefore, the aim of the present work is to study whether dietary Soy regulates the expression of RAS and angiogenesis-related genes and its association with the phosphorylated state of Akt in the adipose tissue of obese rats. Animals were fed a 30 % Soy or casein (Cas) diet containing 5 or 25 % fat for 160 d. mRNA abundance was studied in the adipose tissue, and Akt phosphorylation and hormone release were measured in the primary adipocyte culture. The present results show that Soy treatment in comparison with Cas consumption induces lower angiotensin release and increased insulin-stimulated Akt activation in adipocytes. Furthermore, Soy consumption varies the expression of RAS and angiogenesis-related genes, which maintain cell size and vascularity in the adipose tissue of rats fed a high-fat diet. Thus, adipocyte hypertrophy and impaired angiogenesis, which are frequently observed in dysfunctional adipose tissue, were avoided by consuming dietary Soy. Taken together, these findings suggest that Soy can be used as a dietary strategy to preserve adipocyte functionality and to prevent obesity abnormalities.
Insights
Dietary soy protein intake improves adipocyte function in obese rats by modulating the renin-angiotensin system (RAS) and angiogenesis-related genes, preventing negative metabolic changes.
Area of Science:
- Metabolic disturbances and adipose tissue function in obesity.
- Role of the renin-angiotensin system (RAS) in adipocyte signaling and angiogenesis.
- Impact of dietary soy protein on metabolic health.
Background:
- Obesity is linked to altered adipose tissue function and metabolic disturbances.
- Adipocytes possess a local renin-angiotensin system (RAS) that influences angiogenesis via Akt signaling.
- Dietary soy protein modifies gene expression in adipose tissue, potentially improving adipocyte function.
Purpose of the Study:
- To investigate if dietary soy protein regulates RAS and angiogenesis-related gene expression in obese rats.
- To determine the association between soy consumption, gene expression, and Akt phosphorylation in adipose tissue.
- To evaluate soy's effect on adipocyte function and prevent obesity-related abnormalities.
Main Methods:
- Obese rats were fed diets with soy protein or casein, at varying fat content (5% or 25%), for 160 days.
- mRNA abundance of RAS and angiogenesis-related genes was analyzed in adipose tissue.
- Akt phosphorylation and hormone release were measured in primary adipocyte cultures.
Main Results:
- Soy consumption led to lower angiotensin release and enhanced insulin-stimulated Akt activation in adipocytes compared to casein.
- Dietary soy modulated the expression of RAS and angiogenesis-related genes in high-fat diet-fed rats.
- Soy intake prevented adipocyte hypertrophy and impaired angiogenesis, common in dysfunctional adipose tissue.
Conclusions:
- Dietary soy protein preserves adipocyte functionality in obese rats.
- Soy intake acts as a dietary strategy to prevent obesity-related metabolic abnormalities.
- Modulation of RAS and angiogenesis pathways by soy contributes to improved adipose tissue health.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hormonal Regulation
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers

